Abstract:Target-based drug discovery technology based on cell membrane targets has gained significant traction and has been steadily advancing. However, current methods still face certain limitations that need to be addressed. One of the challenges is the laborious preparation process of screening materials, which can be time-consuming and resource-intensive. Additionally, there is a potential issue of non-specific adsorption caused by carrier materials, which can result in false-positive results and compromise the accuracy of the screening process. To address these challenges, this paper proposes a target-based cell membrane affinity ultrafiltration technology for active ingredient discovery in natural products. In this technique, the cell membranes of human lung adenocarcinoma epithelial cells (A549) with a high expression of epidermal growth factor receptor (EGFR) were incubated with candidate drugs and then transferred to an ultrafiltration tube. Through centrifugation, components that interacted with EGFR were retained in the ultrafiltration tube as "EGFR-ligand" complex, while the components that did not interact with EGFR were separated. After thorough washing and eluting, the components interacting with EGFR were dissociated and further identified using LC–MS, enabling the discovery of bioactive compounds. Moreover, the target-based cell membrane affinity ultrafiltration technology exhibited commendable binding capacity and selectivity. Ultimately, this technology successfully screened and identified two major components from the Curcumae Rhizoma-Sparganii Rhizoma (CS) herb pair extracts, which were further validated for their potential anti-tumor activity through pharmacological experiments. By eliminating the need for laborious preparation of screening materials and the potential non-specific adsorption caused by carriers, the development of target-based cell membrane affinity ultrafiltration technology provides a simplified approach and method for bioactive compounds discovery in natural sources.

A New A431/cell Membrane Chromatography and Online High Performance Liquid Chromatography/mass Spectrometry Method for Screening Epidermal Growth Factor Receptor Antagonists from Radix Sophorae Flavescentis

Ononin, Sec-O-β-d-glucosylhamaudol and Astragaloside I: Antiviral Lead Compounds Identified Via High Throughput Screening and Biological Validation from Traditional Chinese Medicine Zhongjing Formulary.

Development of target-based cell membrane affinity ultrafiltration technology for a simplified approach to discovering potential bioactive compounds in natural products

Application of SNAP-tag-EGFR cell membrane chromatography model in screening antitumor active components of Silybum marianum (L.) Gaertn

Construction of graphene quantum dots-decorated EGFR cell membrane chromatography for screening active components from Peucedanum praeruptorum Dunn

Development of APTES-Decorated HepG2 Cancer Stem Cell Membrane Chromatography for Screening Active Components from Salvia Miltiorrhiza.

[Deep brain stimulation in dysphagia among patients with Parkinson disease. The self-evaluated swallowing function improved in a pilot study].

Identification of Potent EGFR Inhibitors from TCM Database@Taiwan.

Diffusion and Impacts of E-Commerce in the United States of America: Results from an Industry Survey

A System for Screening Agonists Targeting Β2-Adrenoceptor from Chinese Medicinal Herbs

On-line Coupling of Macroporous Resin Column Chromatography with Direct Analysis in Real Time Mass Spectrometry Utilizing a Surface Flowing Mode Sample Holder.

Effects of CS-1 on A431 Cell Proliferation, Cell Cycle, and Epidermal Growth Factor Receptor Signal Transduction

Rapid Screening of Bioactive Compounds from Natural Products by Integrating 5-Channel Parallel Chromatography Coupled with On-Line Mass Spectrometry and Microplate Based Assays.

Development of an LC-MS/MS method for quantifying ASK120067, a novel mutant-selective inhibitor of the epidermal growth factor receptor (EGFR) as well as its main metabolite in human plasma and its application in a pharmacokinetic study

An integrated strategy for the identification and screening of anti-allergy components from natural products based on calcium fluctuations and cell extraction coupled with HPLC–Q–TOF–MS

Frontal Affinity Chromatography Combined On-Line with Mass Spectrometry: a Tool for the Binding Study of Different Epidermal Growth Factor Receptor Inhibitors.

KIT-SNAP-tag/cell membrane chromatography model coupled with liquid chromatography-mass spectrometry for anti-GIST compound screening from Evodia rutaecarpa

The novel application of polyclonal antibodies in recognizing anti-EGFR inhibitors directly from herb

Screening of immune cell activators from Astragali Radix using a comprehensive two-dimensional NK-92MI cell membrane chromatography/C18 column/time-of-flight mass spectrometry system

Selective separation of active inhibitors of epidermal growth factor receptor from Caragana jubata by molecularly imprinted solid-phase extraction

Screening for promising multi-target bioactive components from Cortex Mori Radicis for the treatment of chronic cor pulmonale based on immobilized beta1-adrenergic receptor and beta2-adrenergic receptor chromatography